This stuff isnt meant to glide
Tirzepatide, a dual GIP/GLP-1 receptor agonist approved for diabetes management and weight loss, works through distinct mechanisms from testosterone replacement therapy (TRT), which restores physiological hormone levels in men with confirmed low testosterone
These can make it difficult to eat enough, especially protein, and maintain proper nutrition
However, other areas of the body can be used in specific circumstances
Tim Heise and colleagues [76] conducted a secondary analysis study to assess the effect of tirzepatide 15 mg (N = 45), semaglutide 1 mg (N = 44), and placebo (N = 28) effects on body composition, appetite, and energy intake